CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I Study of the Pan-ERBB Inhibitor Neratinib Given in Combination With Everolimus, Palbociclib, or Trametinib in Advanced Cancer Subjects With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03065387
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:39.248069+00:00
- Published At
- 2026-01-12T00:00:00+00:00
- Record Updated At
- 2026-01-12
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Advanced Malignant Solid Neoplasm", "EGFR Gene Amplification", "EGFR Gene Mutation", "ERBB2 Gene Amplification", "ERBB2 Gene Mutation", "ERBB3 Gene Mutation", "ERBB4 Gene Mutation", "KRAS Gene Mutation", "Metastatic Malignant Solid Neoplasm", "Refractory Malignant Solid Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-12"- protocolSection.identificationModule.nctId
"NCT03065387"- protocolSection.identificationModule.officialTitle
"Phase I Study of the Pan-ERBB Inhibitor Neratinib Given in Combination With Everolimus, Palbociclib, or Trametinib in Advanced Cancer Subjects With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.